Detecting AIDS restriction genes: from candidate genes to genome-wide association discovery (Q48887107)

16 February 2018

title

Detecting AIDS restriction genes: from candidate genes to genome-wide association discovery (English)

1 reference

16 February 2018

genome-wide association study

main subject

0 references

author

Randall Johnson

8

1 reference

16 February 2018

James J Goedert

11

J J Goedert

1 reference

16 February 2018

Sharyne M Donfield

12

S Donfield

1 reference

16 February 2018

Cheryl A Winkler

6

C A Winkler

1 reference

16 February 2018

Stephen J. O'Brien

13

S J O'Brien

1 reference

16 February 2018

author name string

H B Hutcheson

1

1 reference

16 February 2018

J A Lautenberger

2

1 reference

16 February 2018

G W Nelson

3

1 reference

16 February 2018

J U Pontius

4

1 reference

16 February 2018

B D Kessing

5

1 reference

16 February 2018

M W Smith

7

1 reference

16 February 2018

R Stephens

9

1 reference

16 February 2018

J Phair

10

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 February 2008

1 reference

16 February 2018

published in

Vaccine

1 reference

16 February 2018

volume

26

1 reference

16 February 2018

issue

24

1 reference

16 February 2018

page(s)

2951-2965

1 reference

16 February 2018

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Identification of a major co-receptor for primary isolates of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Molecular cloning and functional expression of a new human CC-chemokine receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Human genes that limit AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

The influence of HLA genotype on AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Polygenic and multifactorial disease gene association in man: Lessons from AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Origins of HIV and the evolution of resistance to AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

A novel antiretroviral class (fusion inhibitors) in the management of HIV infection. Present features and future perspectives of enfuvirtide (T-20).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

CCR5 antagonists: host-targeted antivirals for the treatment of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Anti-HIV drug development--an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Using mutual information to measure the impact of multiple genetic factors on AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

A haplotype map of the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Mapping complex disease loci in whole-genome association studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

A worldwide survey of haplotype variation and linkage disequilibrium in the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Transferability of tag SNPs in genetic association studies in multiple populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Efficiency and power in genetic association studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Genome-wide association studies for common diseases and complex traits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Searching for genetic determinants in the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Statistical false positive or true disease pathway?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Genome-wide association studies: theoretical and practical concerns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Determinants of the success of whole-genome association testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Why most published research findings are false

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Replication validity of genetic association studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Genetic associations in large versus small studies: an empirical assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Modulating influence on HIV/AIDS by interacting RANTES gene variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.054

10.1016/J.VACCINE.2007.12.054

7 January 2021

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018